Best matching opportunities for your request
We found 3 current grant opportunities for Startup applicants related to women, led. The highlighted options below are the strongest matches currently available in the Cuberfy database. Review the official source for final eligibility, amounts and deadline details before applying.
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 1 | Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the matc... | Grant Mixed | United States | Award ceiling: $6,250,000 | Open Nov 15, 2027 Open | Grants.gov |
|
Why this matches
This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the applicant profile aligns with startups. Fit notes
Applicant type: Company. Deadline note
Deadline: Nov 15, 2027. Source description
The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD. |
||||||
| 2 | Manufacturing in America E2G Grant Initiative This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the matc... | Grant Cash Grant | United States | Award range: $5,000,000 - $5,000,000 | Deadline Soon Jun 15, 2026 Open | Grants.gov |
|
Why this matches
This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the applicant profile aligns with startups. Fit notes
Applicant type: Company. Deadline note
Deadline: Jun 15, 2026. Source description
The purpose of this Funding Opportunity Announcement is to invite proposals for funding from established organizations interested in providing innovative hands-on, in-person manufacturing training and technical assistance to eligible small manufacturing business concerns, under the U.S. Small Business Administration's Empower to Grow Program (formerly known as 7(j) Management and Technical Assistance Program). |
||||||
| 3 | NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) This result matches because the type, category, tags, or source metadata support the match, the applicant profile aligns with star... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Jan 7, 2027 Open | Grants.gov |
|
Why this matches
This result matches because the type, category, tags, or source metadata support the match, the applicant profile aligns with startups, the summary or source description contains related terms. Fit notes
Applicant type: Company. Deadline note
Deadline: Jan 7, 2027. Source description
The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activities, this FOA will provide support for final stage preclinical activities needed for the implementation of the proposed trial. All the activities proposed in the R61 phase must be directly related to the therapeutic/diagnostic in preparation for the clinical trial. The proposed trial can be single or multisite. This NOFO will utilize a bi-phasic, milestone-driven mechanism of award where the first phase can be used to finalize required pre-trial activities such as stability, shipping studies, and site training. |
||||||